
Sign up to save your podcasts
Or


Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer.
By Dr. Neil Love4.6
1313 ratings
Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer.

154,142 Listeners

320 Listeners

67 Listeners

32 Listeners

75 Listeners

17 Listeners

13 Listeners

0 Listeners

118 Listeners

112,734 Listeners

1,156 Listeners

324 Listeners

57 Listeners

2 Listeners

58 Listeners

189 Listeners

12 Listeners

0 Listeners